According to the latest research analysis,the global market for Molecular Point of Care (POC) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Molecular Point of Care (POC) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Molecular Point of Care (POC) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Respiratory segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Clinical has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Molecular Point of Care (POC) include Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc., Biocartis NV, bioMérieux SA, Cepheid, Credo Bioscience and Curetis NV, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Molecular Point of Care (POC).
Data-Driven Insights: Highlights from Our Report
(1) Global Molecular Point of Care (POC) market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Molecular Point of Care (POC) market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Molecular Point of Care (POC) market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Molecular Point of Care (POC) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Molecular Point of Care (POC) segment by type and by application and regional segment by type and by application.
(6) Molecular Point of Care (POC) industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Respiratory
Other
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Clinical
Research
Understanding Market Segments by Key Players: Insights and Opportunities
Abbott Laboratories
Aidian Oy
Akonni Biosystems
binx health, inc.
Biocartis NV
bioMérieux SA
Cepheid
Credo Bioscience
Curetis NV
DiaSorin S.p.A
GenMark Diagnostics
Greiner Bio-One GmbH
Meridian Bioscience, Inc.
Mesa Biotech, Inc.
QIAGEN NV
QuantuMDx Group
Quidel Corporation
Roche
Sekisui Diagnostics LLC
T2 Biosystems
1 Market Overview
1.1 Product Overview and Scope of Molecular Point of Care (POC)
1.2 Global Molecular Point of Care (POC) Market Size and Forecast
1.3 China Molecular Point of Care (POC) Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Molecular Point of Care (POC) Share in Global Market, 2018-2029
1.4.2 Molecular Point of Care (POC) Market Size: China VS Global, 2018-2029
1.5 Molecular Point of Care (POC) Market Dynamics
1.5.1 Molecular Point of Care (POC) Market Drivers
1.5.2 Molecular Point of Care (POC) Market Restraints
1.5.3 Molecular Point of Care (POC) Industry Trends
1.5.4 Molecular Point of Care (POC) Industry Policy
2 Global Competitive Situation by Company
2.1 Global Molecular Point of Care (POC) Revenue by Company (2018-2023)
2.2 Global Molecular Point of Care (POC) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Molecular Point of Care (POC) Concentration Ratio
2.4 Global Molecular Point of Care (POC) Mergers & Acquisitions, Expansion Plans
2.5 Global Molecular Point of Care (POC) Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Molecular Point of Care (POC) Revenue by Company (2018-2023)
3.2 China Molecular Point of Care (POC) Molecular Point of Care (POC) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Molecular Point of Care (POC), Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Molecular Point of Care (POC) Industry Chain
4.2 Molecular Point of Care (POC) Upstream Analysis
4.3 Molecular Point of Care (POC) Midstream Analysis
4.4 Molecular Point of Care (POC) Downstream Analysis
5 Sights by Type
5.1 Molecular Point of Care (POC) Classification
5.1.1 Respiratory
5.1.2 Other
5.2 By Type, Global Molecular Point of Care (POC) Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Molecular Point of Care (POC) Revenue, 2018-2029
6 Sights by Application
6.1 Molecular Point of Care (POC) Segment by Application
6.1.1 Clinical
6.1.2 Research
6.2 By Application, Global Molecular Point of Care (POC) Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Molecular Point of Care (POC) Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Molecular Point of Care (POC) Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Molecular Point of Care (POC) Market Size, 2018-2029
7.3 North America
7.3.1 North America Molecular Point of Care (POC) Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Molecular Point of Care (POC) Market Size Market Share
7.4 Europe
7.4.1 Europe Molecular Point of Care (POC) Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Molecular Point of Care (POC) Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Molecular Point of Care (POC) Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Molecular Point of Care (POC) Market Size Market Share
7.6 South America
7.6.1 South America Molecular Point of Care (POC) Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Molecular Point of Care (POC) Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Molecular Point of Care (POC) Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Molecular Point of Care (POC) Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Molecular Point of Care (POC) Market Size, 2018-2029
8.3.2 By Company, U.S. Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Molecular Point of Care (POC) Market Size, 2018-2029
8.4.2 By Company, Europe Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Molecular Point of Care (POC) Market Size, 2018-2029
8.5.2 By Company, China Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.5.3 By Type, China Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Molecular Point of Care (POC) Market Size, 2018-2029
8.6.2 By Company, Japan Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Molecular Point of Care (POC) Market Size, 2018-2029
8.7.2 By Company, South Korea Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Molecular Point of Care (POC) Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Molecular Point of Care (POC) Market Size, 2018-2029
8.9.2 By Company, India Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.9.3 By Type, India Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Molecular Point of Care (POC) Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
9.1.2 Abbott Laboratories Company Profile and Main Business
9.1.3 Abbott Laboratories Molecular Point of Care (POC) Models, Specifications and Application
9.1.4 Abbott Laboratories Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.1.5 Abbott Laboratories Recent Developments
9.2 Aidian Oy
9.2.1 Aidian Oy Company Information, Head Office, Market Area and Industry Position
9.2.2 Aidian Oy Company Profile and Main Business
9.2.3 Aidian Oy Molecular Point of Care (POC) Models, Specifications and Application
9.2.4 Aidian Oy Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.2.5 Aidian Oy Recent Developments
9.3 Akonni Biosystems
9.3.1 Akonni Biosystems Company Information, Head Office, Market Area and Industry Position
9.3.2 Akonni Biosystems Company Profile and Main Business
9.3.3 Akonni Biosystems Molecular Point of Care (POC) Models, Specifications and Application
9.3.4 Akonni Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.3.5 Akonni Biosystems Recent Developments
9.4 binx health, inc.
9.4.1 binx health, inc. Company Information, Head Office, Market Area and Industry Position
9.4.2 binx health, inc. Company Profile and Main Business
9.4.3 binx health, inc. Molecular Point of Care (POC) Models, Specifications and Application
9.4.4 binx health, inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.4.5 binx health, inc. Recent Developments
9.5 Biocartis NV
9.5.1 Biocartis NV Company Information, Head Office, Market Area and Industry Position
9.5.2 Biocartis NV Company Profile and Main Business
9.5.3 Biocartis NV Molecular Point of Care (POC) Models, Specifications and Application
9.5.4 Biocartis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.5.5 Biocartis NV Recent Developments
9.6 bioMérieux SA
9.6.1 bioMérieux SA Company Information, Head Office, Market Area and Industry Position
9.6.2 bioMérieux SA Company Profile and Main Business
9.6.3 bioMérieux SA Molecular Point of Care (POC) Models, Specifications and Application
9.6.4 bioMérieux SA Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.6.5 bioMérieux SA Recent Developments
9.7 Cepheid
9.7.1 Cepheid Company Information, Head Office, Market Area and Industry Position
9.7.2 Cepheid Company Profile and Main Business
9.7.3 Cepheid Molecular Point of Care (POC) Models, Specifications and Application
9.7.4 Cepheid Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.7.5 Cepheid Recent Developments
9.8 Credo Bioscience
9.8.1 Credo Bioscience Company Information, Head Office, Market Area and Industry Position
9.8.2 Credo Bioscience Company Profile and Main Business
9.8.3 Credo Bioscience Molecular Point of Care (POC) Models, Specifications and Application
9.8.4 Credo Bioscience Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.8.5 Credo Bioscience Recent Developments
9.9 Curetis NV
9.9.1 Curetis NV Company Information, Head Office, Market Area and Industry Position
9.9.2 Curetis NV Company Profile and Main Business
9.9.3 Curetis NV Molecular Point of Care (POC) Models, Specifications and Application
9.9.4 Curetis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.9.5 Curetis NV Recent Developments
9.10 DiaSorin S.p.A
9.10.1 DiaSorin S.p.A Company Information, Head Office, Market Area and Industry Position
9.10.2 DiaSorin S.p.A Company Profile and Main Business
9.10.3 DiaSorin S.p.A Molecular Point of Care (POC) Models, Specifications and Application
9.10.4 DiaSorin S.p.A Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.10.5 DiaSorin S.p.A Recent Developments
9.11 GenMark Diagnostics
9.11.1 GenMark Diagnostics Company Information, Head Office, Market Area and Industry Position
9.11.2 GenMark Diagnostics Company Profile and Main Business
9.11.3 GenMark Diagnostics Molecular Point of Care (POC) Models, Specifications and Application
9.11.4 GenMark Diagnostics Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.11.5 GenMark Diagnostics Recent Developments
9.12 Greiner Bio-One GmbH
9.12.1 Greiner Bio-One GmbH Company Information, Head Office, Market Area and Industry Position
9.12.2 Greiner Bio-One GmbH Company Profile and Main Business
9.12.3 Greiner Bio-One GmbH Molecular Point of Care (POC) Models, Specifications and Application
9.12.4 Greiner Bio-One GmbH Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.12.5 Greiner Bio-One GmbH Recent Developments
9.13 Meridian Bioscience, Inc.
9.13.1 Meridian Bioscience, Inc. Company Information, Head Office, Market Area and Industry Position
9.13.2 Meridian Bioscience, Inc. Company Profile and Main Business
9.13.3 Meridian Bioscience, Inc. Molecular Point of Care (POC) Models, Specifications and Application
9.13.4 Meridian Bioscience, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.13.5 Meridian Bioscience, Inc. Recent Developments
9.14 Mesa Biotech, Inc.
9.14.1 Mesa Biotech, Inc. Company Information, Head Office, Market Area and Industry Position
9.14.2 Mesa Biotech, Inc. Company Profile and Main Business
9.14.3 Mesa Biotech, Inc. Molecular Point of Care (POC) Models, Specifications and Application
9.14.4 Mesa Biotech, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.14.5 Mesa Biotech, Inc. Recent Developments
9.15 QIAGEN NV
9.15.1 QIAGEN NV Company Information, Head Office, Market Area and Industry Position
9.15.2 QIAGEN NV Company Profile and Main Business
9.15.3 QIAGEN NV Molecular Point of Care (POC) Models, Specifications and Application
9.15.4 QIAGEN NV Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.15.5 QIAGEN NV Recent Developments
9.16 QuantuMDx Group
9.16.1 QuantuMDx Group Company Information, Head Office, Market Area and Industry Position
9.16.2 QuantuMDx Group Company Profile and Main Business
9.16.3 QuantuMDx Group Molecular Point of Care (POC) Models, Specifications and Application
9.16.4 QuantuMDx Group Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.16.5 QuantuMDx Group Recent Developments
9.17 Quidel Corporation
9.17.1 Quidel Corporation Company Information, Head Office, Market Area and Industry Position
9.17.2 Quidel Corporation Company Profile and Main Business
9.17.3 Quidel Corporation Molecular Point of Care (POC) Models, Specifications and Application
9.17.4 Quidel Corporation Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.17.5 Quidel Corporation Recent Developments
9.18 Roche
9.18.1 Roche Company Information, Head Office, Market Area and Industry Position
9.18.2 Roche Company Profile and Main Business
9.18.3 Roche Molecular Point of Care (POC) Models, Specifications and Application
9.18.4 Roche Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.18.5 Roche Recent Developments
9.19 Sekisui Diagnostics LLC
9.19.1 Sekisui Diagnostics LLC Company Information, Head Office, Market Area and Industry Position
9.19.2 Sekisui Diagnostics LLC Company Profile and Main Business
9.19.3 Sekisui Diagnostics LLC Molecular Point of Care (POC) Models, Specifications and Application
9.19.4 Sekisui Diagnostics LLC Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.19.5 Sekisui Diagnostics LLC Recent Developments
9.20 T2 Biosystems
9.20.1 T2 Biosystems Company Information, Head Office, Market Area and Industry Position
9.20.2 T2 Biosystems Company Profile and Main Business
9.20.3 T2 Biosystems Molecular Point of Care (POC) Models, Specifications and Application
9.20.4 T2 Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2018-2023
9.20.5 T2 Biosystems Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|